Background: Pediatric primary spinal cord tumors are rare, accounting for approximately 6% of central nervous system neoplasms. Most published data come from high-income countries (HICs) with access to early diagnosis, intraoperative monitoring, and specialized neuro-oncology units. In low- and middle-income countries...
A. Durrani, Ahsan Ahmad, F. Nisar et al.· Surgical neurology internati...· 0 citations
Immunotherapy has transformed the management of several extracranial malignancies; however, its efficacy in GBM has been limited. Large clinical trials evaluating immune checkpoint inhibitors have failed to demonstrate meaningful survival benefit in newly diagnosed and recurrent GBM. Other modalities, including dendrit...
Osama Salar, Mehar Masroor, K. Chaudhary et al.· JOURNAL OF PAKISTAN MEDICAL...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.